The frontier biomedical laboratory of Kaneka has screened a new (Pediococcus acidilactici R037) from about 100 Lactobacillus lactis strains which reduces neutral fat in blood.
Airi Tategawa, Kaneka Co., lecture at Kitasato University Lactobacillus Symposium, May 25
Kaneka, Osaka University: Pediococcus acidilactici R037 has immunomodulatory function and reduces neutral fat in humans